You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Cadila Healthcare Ltd"

Cadila Healthcare Ltd Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regula

  • 13/04/2017
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 10/04/2017
  • |
  • bse

Cadila Healthcare Ltd Statement Of Investor Complaints As On March 31 2017.

  • 10/04/2017
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 07/04/2017
  • |
  • bse

Cadila Healthcare Ltd Compliance Certificate Under Regulation 7(3) Of LODR - 2015 For The Half Year Ended March 31 2017

  • 06/04/2017
  • |
  • bse

Cadila Healthcare Ltd Voting Results Of The Meeting Of Equity Shareholders Of The Company Held On March 30 2017 Pursuant T

  • 01/04/2017
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 30/03/2017
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 22/03/2017
  • |
  • bse

Cadila Healthcare Ltd Updates

  • 15/03/2017
  • |
  • bse

Cadila Healthcare Ltd Press Release

  • 08/03/2017
  • |
  • bse

Cadila Healthcare Ltd Outcome of Board Meeting

  • 07/03/2017
  • |
  • bse

Cadila Healthcare Ltd Press Release

  • 07/03/2017
  • |
  • bse

Cadila Healthcare Ltd Press Release

  • 02/03/2017
  • |
  • bse

Cadila Healthcare Ltd Credit Rating

  • 02/03/2017
  • |
  • bse

Cadila Healthcare Ltd Newspaper Advertisements for Notice convening the meetings of the Equity Shareholders Secured Credit

  • 27/02/2017
  • |
  • bse

Cadila Healthcare Ltd Zydus Nesher Pharmaceuticals receives final approval from the USFDA for Oseltamivir Phosphate Capsul

  • 27/02/2017
  • |
  • bse

Cadila Healthcare Ltd Zydus Cadila to launch India?s 1st Tetravalent Inactivated Influenza vaccine - VaxiFlu - 4

  • 24/02/2017
  • |
  • bse

Cadila Healthcare Ltd Tribunal Convened Meeting on March 30 2017

  • 23/02/2017
  • |
  • bse

Cadila Healthcare Ltd Zydus receives approval from USFDA to initiate Phase II clinical studies of Saroglitazar Magnesium i

  • 23/02/2017
  • |
  • bse

Cadila Healthcare Ltd Investor Presentation

  • 21/02/2017
  • |
  • bse